{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001907108","name":"Lexeo Therapeutics, Inc.","summary":"Lexeo Therapeutics is a clinical-stage genetic medicine company focused on cardiovascular gene therapies. Its lead candidate, LX2006 (AAVrh10-based), targets Friedreich ataxia cardiomyopathy and is in Phase 1/2 trials. LX2020 targets PKP2-arrhythmogenic cardiomyopathy, also in Phase 1/2. Additional pipeline candidates include LX2021 (Cx43, DSP cardiomyopathy), LX2022 (TNNI3, hypertrophic cardiomyopathy), and LX1001 (APOE4-associated Alzheimer's disease). The company uses AAVrh10 vectors and a proprietary Sf9 baculovirus manufacturing platform.","people":[],"products":[{"name":"LX2006","type":"platform","description":"AAVrh10-based gene therapy delivering functional FXN gene for Friedreich ataxia cardiomyopathy; in Phase 1/2 trial (SUNRISE-FA)."},{"name":"LX2020","type":"platform","description":"AAVrh10-based gene therapy delivering functional PKP2 gene for PKP2-arrhythmogenic cardiomyopathy; in Phase 1/2 trial (HEROIC-PKP2)."},{"name":"LX2021","type":"platform","description":"Gene therapy delivering Cx43 coding sequence targeting DSP cardiomyopathy and certain dilated cardiomyopathies."},{"name":"LX2022","type":"platform","description":"Gene therapy delivering functional TNNI3 gene to treat hypertrophic cardiomyopathy caused by TNNI3 mutations."},{"name":"LX1001","type":"platform","description":"Gene therapy candidate targeting APOE4-associated Alzheimer's disease; completed Phase 1/2 clinical trial; seeking business development."}],"partnerships":[{"partner_name":"Weill Cornell Medical College","partnership_type":"licensing","description":"In-licensed product candidates with established preclinical proof-of-concept; Weill Cornell conducted preclinical AAVrh10 biodistribution studies.","start_date":null}],"affiliations":[],"origin":{"leaf":"408aa825e28f0c732ec31b11fb2fbc91d270a7ef820e0fc05a1798f4e53f2e70","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"e027c94ab3c9bad14d008cbe4c68fa1b0efc6aefb46cd803f5107aadb2e0011e","parent":"08756ef1d137193f039e9d68f57b4e977c3d2e18c288568b7bdfc53b88ba39f2","source":"0001193125-26-132085","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":214,"hourly_limit":500,"remaining":286,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}